MaxCyte, Inc. (MXCT)

MaxCyte Revenue

MaxCyte had revenue of $44.05M in the twelve months ending March 31, 2024, with 6.80% growth year-over-year. Revenue in the quarter ending March 31, 2024 was $11.34M with 32.25% year-over-year growth. In the year 2023, MaxCyte had annual revenue of $41.29M, a decrease of -6.72%.

• Revenue (ttm): $44.05M
• Revenue Growth: +6.80%
• P/S Ratio: 11.17
• Revenue / Employee: $308,068
• Employees: 143
• Market Cap: 491.88M USD

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2023	41.29M	-2.97M	-6.72%
Dec 31, 2022	44.26M	10.37M	30.59%
Dec 31, 2021	33.89M	7.73M	29.52%
Dec 31, 2020	26.17M	4.55M	21.04%
Dec 31, 2019	21.62M	-	-

Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.